Metformin, but not pioglitazone, decreases postchallenge plasma ghrelin levels in type 2 diabetic patients: a possible role in weight stability?
Format: | Article |
---|---|
Language: | English |
Published: |
Endocrinology Research Centre
2009-06-01
|
Series: | Ожирение и метаболизм |
Online Access: | https://www.omet-endojournals.ru/jour/article/view/5321 |
Similar Items
-
Metformin, but not pioglitazone, decreases postchallenge plasma ghrelin levels in type 2 diabetic patients: a possible role in weight stability.
Published: (2009-03-01) -
Pioglitazone and metformin.
by: Hill, N, et al.
Published: (2007) -
Pioglitazone/metformin - Viewpoint
by: Matthews, DR
Published: (2006) -
Safety and tolerability of pioglitazone, metformin, and gliclazide in the treatment of type 2 diabetes.
by: Belcher, G, et al.
Published: (2005) -
Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
by: Holl, et al.
Published: (2014-07-01)